New contraceptive implants are becoming available to family planning programs around the world—the one-rod system Implanon®, the two-rod system Jadelle®, and in some countries Sino-implant (II)®, also two rods. Norplant®, the six-capsule implant system, is no longer be available. The new contraceptive implants hold substantial promise and are likely to broaden the appeal of the method. They are an important option in the range of long-acting methods. As family planning programs begin introducing the new implants or making the transition from Norplant, demand can be expected to rise. To meet the demand, programs will need to rely on donor and government subsidies, greater availability of lower-priced implants, and sharing the cost with users. Such strategies to improve access at lower cost will be key to the success of this contraceptive method.